Two Sigma Advisers’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.19K | Sell |
|
|||||
|
2025
Q1 | $40.7K | Buy |
|
|||||
|
2024
Q4 | $38.1K | Buy |
|
|||||
|
2024
Q3 | $11.4K | Sell |
|
|||||
|
2024
Q2 | $32.5K | Sell |
|
|||||
|
2024
Q1 | $72.9K | Sell |
|
|||||
|
2023
Q4 | $47.5K | Sell |
|
|||||
|
2023
Q3 | $50.3K | Sell |
|
|||||
|
2023
Q2 | $89.7K | Buy |
|
|||||
|
2023
Q1 | $37.1K | Buy |
|
|||||
|
2022
Q4 | $44.2K | Sell |
|
|||||
|
2022
Q3 | $33K | Sell |
|
|||||
|
2022
Q2 | $60K | Sell |
|
|||||
|
2022
Q1 | $216K | Buy |
|